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The quality of dialysate: An integrated approach. The role of ponents of the outer cell wall of gram-negative microor-
bacterial contamination of dialysis water with respect to ganisms. These large substances of bacterial origin and
chronic inflammatory diseases associated with long-term hemo- their fragments of small molecular sizes are releaseddialysis therapy has been greatly underestimated in the last
from bacterial debris. Together with matrix proteins andtwo decades. In the present article, recent multicenter studies
exotoxins, which are actively secreted from living bacte-assessing the bacteriological quality of water and dialysate are
discussed. In addition, we describe that pyrogenic substances of ria, LPS and peptidoglycans form a second layer called
bacterial origin derived from contaminated dialysate penetrate biofilm on the inner surface of water and dialysate tub-
intact dialyzer membranes with the consequence of the induc- ings. From this biofilm, bacterial fragments of varioustion of an inflammatory response in the patients. The influence
molecular sizes may be released into the flowing dialysateof dialyzer membrane characteristics on the passage of bacterial
in an unpredictable manner and may reach the dialyzer insubstances from dialysate into blood are discussed. Reaching
the patients blood, bacteria-derived substances activate circu- which these substances of bacterial origin are separated
lating mononuclear cells to produce proinflammatory cytokines. from the patient’s blood only by the semipermeable dia-
Cytokines such as interleukin-1b and tumor necrosis factor-a
lyzer membrane. If LPSs (endotoxins), peptidoglycans,are mediators of the acute phase response resulting in elevated
exotoxins, and their fragments of small molecular weightlevels of acute phase proteins (for example, C-reactive protein).
The consequence is a state of microinflammation that may (,5 kD) penetrate intact dialyzer membranes, they will
contribute to progressive inflammatory diseases in chronic re- induce an inflammatory response in the patients and
nal failure such as b2-microglobulin amyloidosis, protein catab- eventually a febrile reaction. Because of the risk of pyro-
olism, and atherosclerosis. The use of sterile dialysate reduces
genic reactions, the pyrogen permeability of dialyzercytokine production and plasma levels of acute phase proteins,
membranes is an important aspect with respect to dia-and may positively influence progressive inflammatory diseases
in patients with end-stage renal failure. lyzer biocompatibility. This issue became of particular
importance, since high-flux membranes with high ultra-
filtration coefficients and the occurrence of backfiltration
Why is the bacterial contamination of water and dialy- are increasingly used. More recently, multipurpose dial-
sate an issue today? The bacteriological quality of dialy- ysis monitors producing dialysate as well as replacement
sate has been improved substantially during the last 20 fluid for online hemofiltration and hemodiafiltration
years because of the worldwide use of reverse osmosis have been introduced. Since in the latter treatment mo-
units in the water-preparation systems. On the other dalities the online produced dialysate is infused directly
hand, the almost universal use of sodium bicarbonate into the blood stream of the patient, it has to be sterile
instead of sodium acetate to buffer dialysate has in- and pyrogen free.
creased the risk of severe bacterial contamination of The obvious clinical effect of hemodialysis with se-
dialysate. This is due to the fact that bicarbonate pro- verely contaminated dialysate is a pyrogenic reaction
motes the growth of microorganisms commonly detected with fever and cardiovascular instability. According to
in water and dialysate. So called water-born bacteria data from the United States, approximately 22% of he-
include several Pseudomonas species, including P. aeru- modialysis centers report more than one pyrogenic reac-
ginosa, P. maltophilia, and P. vesicularis, as well as other tion per year [2]. This number remained stable in the
gram-negative bacteria such as Alcaligenes species, Mor- years from 1989 until 1994, despite improvements in the
axella, and Corynebacteria. In addition, several species water pretreatment systems. According to these data,
of fungi and yeast can be found [1]. Lipopolysaccharides one can estimate the incidence of pyrogenic reactions to
(LPSs) and peptidoglycans are the main structural com- be approximately 1:10,000 hemodialysis treatment ses-
sions. With respect to progressive inflammatory diseases
(amyloidosis, catabolism) or progressive diseases with aKey words: biocompatibility, endotoxin, bacteria, hemodialysis, chronic
inflammatory disease. contributing role of low-grade inflammation (atheroscle-
rosis), subclinical effects such as the activation of mono-Ó 2000 by the International Society of Nephrology
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cytes, macrophages, and neutrophils with the subsequent Today, there is no standard for ultrapure fluid, but there
is a general agreement that ultrapure dialysate shouldproduction and release of proinflammatory cytokines
and acute phase proteins seem to be highly relevant. contain less than 0.1 CFU/mL and no detectable endo-
toxin (,0.03 EU/mL).The following paragraphs discuss the degree of bacte-
rial contamination in dialysate in modern dialysis units Bacterial growth in water and dialysate samples is
dramatically influenced by the microbiological methodsand important aspects concerning the monitoring of the
bacteriological quality of dialysate. In vitro dialysis ex- applied [1]. These mentioned standards are only valid
in combination with the use of appropriate techniques.periments describing factors influencing the permeability
of different dialyzer membranes are discussed. Further- To determine bacterial growth in water and dialysate
correctly, it is highly recommended to use nutrient-poormore, a series of in vivo studies is discussed, in which
the use of sterile dialysate reduces monocyte activation, agar [R2A, or tryptone glucose extract (TGE)] in plate
count agar methods, and a prolonged incubation timecytokine production, and plasma levels of acute phase
proteins. Finally, we deal with investigations (both basic of seven days at room temperature (17 to 238C) instead
of body temperature [1, 3]. To assess the growth of fungiand clinical) suggesting that a reduction or even preven-
tion of a subclinical inflammatory response may reduce and yeast in water and dialysate, malt extract agar
(MEA) in combination with the culture conditions de-the prevalence, decrease the severity, or slow down the
progression of life-threatening complications of long- scribed previously in this article should be used.
Water and dialysate samples have to be taken underterm hemodialysis such as b2-microglobulin amyloidosis,
muscle protein wasting, and atherosclerosis. aseptic conditions and stored in pyrogen-free tubes at 4
to 88C. Samples should either be tested in the dialysis
unit or be shipped to a specialized laboratory and assayed
BACTERIAL CONTAMINATION OF DIALYSIS
within 24 hours using the culture conditions outlined pre-
WATER AND DIALYSATE
viously in this article and a quantitative Limulus amoebo-
In the beginning of routine hemodialysis therapy when cyte lysate (LAL) test for the determination of endotoxin.
only softeners were used to prepare dialysis water and The lower detection limit of the LAL assay should be at
dialysate was mixed and heated to 378C in tanks, severe least 0.03 EU/mL. Finally, the time and site of sampling
bacterial contamination of dialysate was very common should be standardized. According to the DAfKN guide-
and resulted in pyrogenic reactions most likely caused lines, reverse-osmosis water samples should be taken at
by the passage of bacterial endotoxin from dialysate into different sites of the loop pipe using sterile connection
blood via membrane ruptures in the self-made Kiil dia- sites after discarding 10 L of water. Dialysate samples
lyzers. Standards concerning the bacteriological quality should be taken at the end of a hemodialysis session
of dialysis water have been proposed. The guidelines of from the dialysate tubing just before or after the dialyzer
the American Association of Medical Instrumentation either by disconnection of the tubings from the dialyzer
(AAMI) allow bacterial growth of no more than 200 col- or by using sterile sampling sites in the dialysate tubings.
ony-forming units (CFU)/mL in water and 2000 CFU/mL The samples should be collected in pyrogen-free tubes
in dialysate. In addition to bacterial growth, there are after discarding 1 L of dialysate.
also standards concerning the endotoxin concentration During the last decade, several multicenter studies were
in water and dialysate. The AAMI standards allow up performed to assess the microbiological quality of water
to 5 endotoxin units (EU) per milliliter in water as well as and dialysate in the United States and Canada as well
in dialysate. More recently, the German Renal Society, as in Europe [4–7]. The results are summarized in Table 1.
Deutsche Arbeitsgemeinschaft fu¨r klinische Nephrologie In comparison to the AAMI standards allowing a bacte-
(DafKN), proposed better standards, allowing only 100 rial growth of 200 CFU/mL in water and 2000 CFU/mL
CFU/mL of bacterial growth and 0.25 EU/mL of endo- in dialysate, these studies show that 7.4 to 35.3% of water
toxin in water. These standards were adopted from the samples and 11.7 to 36.3% of dialysate samples were out
European Pharmacopoe for drinking water. With respect of compliance with the AAMI standards. Testing water
to dialysate contamination, the DAfKN recommends up- and dialysate for endotoxin, up to 44% of samples con-
per limits of 1000 CFU/mL and 0.5 EU/mL for bacterial tained more than 5 EU/mL of endotoxin. When the type
growth and endotoxin, respectively. The definition of ster- of microorganisms were described in the most recent
ile fluid is a content of less than 1026 CFU/mL (,1 CFU study performed in Greece [7], it is most disturbing that
in 1000 L) and no detectable endotoxin (detection limit not only one third of the dialysate samples were contami-
of the endotoxin assays 0.03 EU/mL). This definition nated with more than 2000 CFU/mL, but that 30% of
cannot be used to describe the quality of dialysate pro- these highly contaminated dialysate samples contained
duced by online hemodialysis monitors, because 1000 L faecal coliforms (such as Escherichia coli), which had
are never produced in one session. To overcome this not been detected at all in the three other studies. It
should be emphasized that only in the study conductedproblem, the new term “ultrapure” has been created.
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Table 1. Microbiological quality of water and dialysate in the United States, Canada, and Europe
Bacterial growth Endotoxin
% of samples above % of samples above
Study (location) N AAMI standardsa 5 EU/mL
Klein et al, 1990 (USA)
Water 150 35.3 2
Dialysate 150 19.0 6
Bambauer et al, 1994 (Germany)
Water 90 17.8 12.2
Dialysate 360 11.7 27.5
Laurence et al, 1995 (Canada)
Water 3547/1112b 31.8 44.0
Dialysate not done
Arvanitidou et al, 1998 (Greece)
Water 255 7.4 not done
Dialysate 255 36.3 not done
(30% fecal coliform)
a AAMI standards: water, 200 CFU/mL; dialysate, 2000 CFU/mL
b 5 for bacterial growth, N 5 3547; for endotoxin N 5 1112
center in which decentralized production of dialysate
from reverse-osmosis water and bicarbonate-buffered
concentrate is performed. In 79% of the 62 dialysate
samples, bacterial growth was below 200 CFU/mL. There
was no sample containing more than 1000 CFU/mL, thus
fulfilling the AAMI standards as well as the higher stan-
dards of the DAfKN.
PYROGENIC SUBSTANCES OF BACTERIAL
ORIGIN AND THEIR DETECTION
Lipopolysaccharides, also called endotoxins, are struc-
tural elements of the outer cell wall of gram-negativeFig. 1. Bacterial growth in dialysate (single-center study, N 5 62 sam-
bacteria and are clearly the most important exogenousples).
pyrogens present in contaminated dialysate. The intact
LPS molecule and LPS fragments containing the lipid
A subunit can be measured specifically by the LAL assay.by Klein et al were adequate microbiological techniques
In addition to LPS, there are more components of thewith nutrient-poor culture agars (R2A) and prolonged
bacterial cell wall such as peptidoglycans, fragmentsincubation times at room temperature used [4]. With this
thereof such as muramyl-dipeptides, and other undefinedinformation in mind, one may speculate that bacterial
substances as well as exotoxins, which are actively se-growth is underestimated in the studies by Tokars et al
creted from microorganisms (for example, exotoxin A[2], Bambauer et al [5], Laurence and Lapierre [6], and
of P. aeruginosa). None of these substances of bacterialArvanitidou et al [7] by a factor of up to 100.
origin are detected by the LAL assay. Their biologicalTaken together, bacterial contamination is an impor-
(and potentially pyrogenic) activity can be measured intant problem in today’s routine hemodialysis therapy.
a bioassay called cytokine-induction assay, because theNephrologists need to be aware of this problem and
main activity of exogenous pyrogens (bacterial products)should test routinely, for example, once a month, the
is to induce the synthesis and release of endogenousmicrobiological quality of the dialysis water in their units.
pyrogens [cytokines such as interleukin-1 (IL-1) and tu-If dialysate tests are done routinely, contaminated dial-
mor necrosis factor-a (TNF-a)] in blood monocytes andysis monitors can be identified and special procedures,
macrophages (mononuclear cells, PBMC). In the cyto-including exchange of dialysate tubings and additional
kine-induction assay, human donor PBMCs were incu-sterilization of the entire dialysate circuit using chemicals
bated with samples containing an unknown amount ofand heat, should be performed to decrease bacterial
cytokine-inducing substances (CIS), for example, bacterialgrowth. Following such protocols, it is possible to control
products in contaminated dialysate. During an 18- to 24-the bacterial contamination of dialysis water and dialy-
hour incubation, PBMCs produce and release cytokinessate and keep the quality within the recommended stan-
dards. Figure 1 shows the results of a single hemodialysis such as IL-1b and TNF-a in response to CIS. Cytokines
Lonnemann: Biocompatibility of dialysate S-115
measured by quantitative immunoassays in PBMC cul- of the hollow fibers that is supported by a thick sponge-
like porous structure. Coming from the dialysate side,tures can be used as a readout of CIS present in the
sample. The cytokine-induction assay is nonspecific but CIS first enter the support structure in which adsorption
to hydrophobic membrane domains is very likely. Fi-highly sensitive in measuring the CIS (5 pyrogenic) ac-
tivity in contaminated fluids such as dialysate. nally, the third mechanism involved in pyrogen perme-
ability is the formation of a second layer of plasma pro-
teins on the dialyzer membrane facing the blood side, a
PERMEABILITY OF DIALYZER MEMBRANES
mechanism called protein coating. It has been shown
TO SUBSTANCES OF BACTERIAL ORIGIN:
that protein coating is more pronounced on polysulfone
IN VITRO STUDIES
membranes than on cellulose triacetate membranes [13].
We and others have used the cytokine-induction assay In the same study, we could show that protein coating
to test the permeability of various dialyzer membranes reduces significantly the pyrogen permeability of poly-
to CIS derived from purposefully contaminated dialysate sulfone membranes. In summary, these in vitro studies
during in vitro dialysis experiments [8–12]. When micro- demonstrate that the ability of the membrane polymer
organisms isolated from contaminated dialysate were to adsorb CIS either by direct interactions between hy-
grown in bicarbonate-buffered dialysate and a culture drophobic membrane domains and CIS or by formation
filtrate (0.45 mm filters) of this highly contaminated dialy- of a CIS-adsorbing protein layer caused by protein coat-
sate containing all relevant CIS was used to challenge ing is more important than the pore size of the membrane
dialyzer membranes, dialyzer membrane-dependent dif- in order to reduce pyrogen permeability. Based on the
ferences were observed. The most surprising but repro- extraordinary pyrogen-adsorbing capacity in the pres-
ducible finding of these in vitro studies was that the low- ence of high water permeability, synthetic polyamide
flux cuprophan membrane was more permeable than and polysulfone high-flux membranes have been intro-
some synthetic high-flux membranes (such as polyamide duced as pyrogen filters to produce ultrapure and pyro-
and polysulfone) [9, 12]. These results indicate that con- gen-free dialysate and substitution fluid in online treat-
taminated dialysate contains CIS of small molecular size ment modalities.
(,5 kD), which are able to penetrate cellulosic low-flux
membranes [8]. However, why are some high-flux mem-
PYROGEN PERMEABILITY OF DIALYZERbranes with higher ultrafiltration coefficients and a higher
MEMBRANES: IN VIVO STUDIESmembrane cutoff (approximately 30 to 40 kD) less per-
meable than low-flux cuprophan? Subsequent studies In vivo studies were performed to test whether standard
hemodialysis with moderately contaminated bicarbonaterevealed that three important characteristics of the dia-
lyzer membrane influence the degree of pyrogen-perme- dialysate fulfilling the recommended microbiological stan-
dards in combination with pyrogen-permeable dialyzerability of the membrane: First, the membrane polymer
is able to adsorb bacteria-derived CIS in contaminated membranes results in increased cytokine production in
chronic hemodialysis patients. In a first approach, 11 end-dialysate. Many CISs such as LPS and lipid A-bearing
LPS fragments are hydrophobic because they are rich stage renal disease (ESRD) patients on chronic hemodi-
alysis with low-flux cuprophan dialyzers were studied inin lipids. These hydrophobic substances can be adsorbed
by hydrophobic surfaces. In contrast to the entirely hy- an A-B/B-A crossover design with standard bicarbonate
dialysate (A) or ultrafiltered bicarbonate dialysate (B)drophilic cellulosic membranes such as low-flux cupro-
phan, Hemophan, and high-flux cellulose diacetate and [14]. Four patients started with period A followed by
period B, the remaining seven patients started with ul-triacetate, the synthetic membranes polyamide and poly-
sulfone consist of a copolymer bearing hydrophilic as well trafiltered dialysate (B) and switched to unfiltered dialy-
sate (B). Ultrafiltration of dialysate was done using poly-as hydrophobic domains on the surface. These synthetic
polymers adsorb CIS to the hydrophobic domains caused sulfone F80 high-flux dialyzers (Fresenius, Heidelberg,
Germany). Study periods of eight weeks each with deter-by hydrophobic interaction. Second, an important differ-
ence is the membrane thickness [9]. The thickness of mination of dialysate bacteriology and endotoxin levels
every two weeks were performed. Blood samples werecellulosic low-flux membranes is only 6.5 to 8 mm,
whereas that of synthetic membranes is approximately taken after the long interdialytic interval immediately
before start of the hemodialysis session at least three to35 to 50 mm. The membrane thickness determines, in
part, the diffusive resistance of the dialyzer membrane. six times per period and patient. PBMCs were separated
from blood by Ficoll Hypaque centrifugation, washed,Because diffusion seems to be the predominant transport
mechanism of CIS across the dialyzer membrane, a resuspended in tissue culture medium in a concentration
of 2.5 3 106 PBMC/mL, and frozen at 2708C. After threethicker membrane will be less permeable than a thin
membrane. The synthetic membranes consist of two thaw-freeze cycles, cell-associated IL-1 receptor antago-
nist (IL-1Ra) was measured by specific radioimmunoas-components: a thin skin-like surface on the blood side
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Fig. 2. Content of interleukin 1 receptor antagonist (IL-1Ra) in periph- Fig. 3. Content of IL-1Ra in PBMCs isolated from the same ESRD
eral blood mononuclear cells (PBMCs) isolated from the same end- patients (N 5 9) on nonfiltered dialysate with either low-flux cuprophan
stage renal disease (ESRD) patients (N 5 11) on low-flux cuprophan dialyzers (left) or high-flux polysulfone F60 dialyzers (right). The sym-
hemodialysis with ultrafiltered dialysate (right) or nonfiltered dialysate bols represent the mean of three to six measurements. The horizontal
(left). The symbols represent the mean of three to six measurements. bars indicate the group means (P , 0.013).
The horizontal bars indicate the group means (P , 0.02).
say in PBMC lysates as a marker of in vivo activation tients when the pyrogen-permeable low-flux cuprophan
of PBMCs in ESRD patients [14]. PBMC-IL-1Ra concen- dialyzers were replaced by pyrogen-adsorbing high-flux
trations were averaged per patient and study period. The polysulfone F60 dialyzers. Comparing the two study peri-
results are shown in Figure 3. Bacterial growth was 148 ods, cell-associated IL-1Ra was significantly lower during
(range 61 to 400) CFU/mL in standard dialysate (period A) the F60 compared with the cuprophan period (P , 0.02).
and 0 CFU/mL in period B with ultrafiltered dialysate. The Taken together, the two studies provide evidence that
even moderately contaminated dialysate induces mono-endotoxin concentrations were 80 (range 14 to 10,000)
nuclear cell activation with the consequence of cytokinepg/mL [0.40 (0.07 to 2.0) EU/mL] in unfiltered dialysate
production if dialyzers with pyrogen-permeable mem-and 2 (0 to 4) pg/mL (0.01 EU/mL) in ultrafiltered dialy-
branes are used. This dialysate-dependent activation ofsate. Compared with period A, the IL-1Ra content in
PBMCs can be reduced either by using ultrapure dialy-PBMCs was decreased in 10 out of 11 patients in period
sate or by replacing the pyrogen-permeable dialyzerB using ultrafiltered dialysate. The group mean of
membrane by a pyrogen-adsorbing synthetic dialyzerPBMC-IL-1Ra dropped significantly (P , 0.02) when
membrane.standard dialysate was replaced by ultrafiltered dialysate
(Fig. 2) [14].
In a second study of similar cross over design, nine C-REACTIVE PROTEIN AS AN INDICATOR OF
ESRD patients were studied during two study periods CHRONIC INFLAMMATION IN ESRD PATIENTS
of eight weeks each. Standard, nonfiltered bicarbonate The proinflammatory cytokines IL-1b and TNF-a
dialysate was used throughout the study. Bacterial growth have a very short plasma half-life after release from
was 159 (range 22 to 600) CFU/mL, and the dialysate activated PBMCs into the blood caused by rapid endoge-
endotoxin concentration was 36 (3 to 142) pg/mL [0.18 nous clearance [15]. Therefore, the measurement of
(0.015 to 0.72) EU/mL]. Hemodialysis was performed plasma levels of IL-1b and TNF-a failed to give reliable
either with low-flux cuprophan dialyzers (period A) or and reproducible results. To study the activation of these
with high-flux polysulfone F60 dialyzers (period B). Five cytokines, cell-associated levels in PBMCs instead of
patients started with cuprophan followed by F60 dialyz- plasma levels should be measured [14]. However, IL-1b
ers, and the remaining four patients started with high-flux and TNF-a induce other cytokines, including IL-6 in
F60 and then switched to low-flux cuprophan. Repeated circulating PBMCs, as well as in various tissues. IL-6
measurements of IL-1Ra in PBMC lysates were averaged has a longer plasma half-life compared with IL-1b and
per patient and study period. Results are shown in Figure 3. TNF-a and is one of the most potent activator of hepato-
cytes leading to increased production and release ofPBMC-IL-1Ra content dropped in eight out of nine pa-
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Fig. 4. Plasma levels of C-reactive protein (CRP) in ESRD patients
on long-term hemodialysis with low-flux polysulfone dialyzers (N 5 72).
acute-phase proteins such as C-reactive protein (CRP),
serum amyloid A, ferritin, and others. At the same time,
Fig. 5. Plasma levels of CRP in ESRD patients on long-term hemodial-
the synthesis of serum albumin is significantly reduced ysis with low-flux polysulfone dialyzers treated with either ultrafiltered
dialysate (N 5 18, left) or nonfiltered dialysate (N 5 54, right). Thein hepatocytes in the presence of IL-6. The cytokine-
horizontal bars represent the group means, which are not significantlyinduced switch in hepatocytes from albumin synthesis
different.
to increased production of acute-phase proteins is an
important feature in inflammation. On a subclinical level,
the cytokine-driven microinflammation may not result
in clinical signs of inflammation such as fever and hypo- inflammation. Taken together, approximately one third
tension, but it might be detected by elevated plasma of the patients in our study population had elevated
levels of CRP and, in the same time, decreased levels of CRP levels. CRP levels correlated inversely with serum
serum albumin. albumin levels in the 72 patients. These data confirm
We measured serum CRP levels in 72 ESRD patients recent publications describing a state of inflammation in
on chronic hemodialysis for at least one year at the time ESRD patients, as indicated by elevated IL-6 and CRP
of the study. Patients with diagnosed viral or bacterial levels [16, 17]. In these studies, elevated IL-6 and CRP
infections or known chronic inflammatory diseases (vas- levels were not only correlated with decreased serum
culitis, lupus erythematodes, hepatitis) were excluded albumin but also with markers of malnutrition such as
from the study. All patients were treated for 12 months decreased lean body mass and reduced midarm muscle
with low-flux polysulfone dialyzers (Hemoflow F5 and F6; area [17]. To test whether the long-term exposure to
Fresenius), for four to five hours three times a week with moderately contaminated dialysate could be responsible
bicarbonate-buffered dialysate. Fifty-four patients were for the inflammatory response seen in chronic ESRD
treated with standard nonfiltered dialysate with a bacte- patients on low-flux polysulfone dialyzers, we compared
rial contamination of 95 (range 14 to 1000) CFU/mL. patients treated for at least one year with ultrafiltered
Eighteen patients were treated with ultrafiltered dialy- dialysate (N 5 18) to those treated for the same period
sate (Diasafe; Fresenius), which showed no detectable of time with standard nonfiltered dialysate in the same
bacterial growth when tested under optimized condi- hemodialysis unit (N 5 54). The results depicted in Fig-
tions, as outlined previously in this article. The CRP ure 5 show a wide scatter in both groups, with no differ-
results are summarized in Figure 4: 36% of the patients ence comparing the group means. These data suggest
had no detectable CRP levels (,3.3 mg/L), and 26.5% that in long-term hemodialysis with synthetic low-flux
of the patients had CRP levels between 3.4 and 8.0 mg/L. dialyzers with pyrogen-adsorbing capacity, a low-grade
Taken together, 62.5% of the patients had CRP plasma contamination of dialysate has no significant effect on
levels below the level of clinical relevance, which is 8 CRP levels in ESRD patients. The influence of various
mg/L in the assay used. However, 22.2% of the patients dialyzer membranes on CRP levels in ESRD patients
had slightly elevated CRP levels of 8.1 to 16 mg/L, and was not investigated in this study. However, a recent
15.3% had significantly elevated CRP levels of 16.1 to work by Schindler et al studied 18 ESRD patients treated
with moderately contaminated bicarbonate dialysate50 mg/L in the absence of clinical signs of infection or
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(20.5 6 5.8 CFU/mL, range 0 to 100) and three different macrophages to produce proinflammatory cytokines. IL-1
and TNF-a activate collagenases leading to matrix degra-dialyzer membranes in randomized order [18]. The mem-
branes tested were low-flux cuprophan (Alpha 600 plate; dation, inhibit osteoblasts and bone formation, and at
the same time, activate osteoclasts resulting in bone re-Gambro, Germany), low-flux synthetic polycarbonate-
polyether (Gambrane, Pro 600 plate; Gambro, Sweden), sorption. In summary, these data suggest an important
role of activated monocytes, cytokines, and a local in-and high-flux polyamide (Polyflux PF14 hollow-fiber;
Gambro, Germany). Every membrane was used for eight flammatory response in the development of amyloidosis
and bone cyst formation. How important is hemodialysis-weeks, and whole blood content of IL-1Ra and plasma
levels of CRP were determined before the start of the dependent activation of monocytes in b2-microglobulin
amyloidosis? There is only little indirect evidence thatfirst weekly hemodialysis session during the last six weeks
of every period. Whole blood IL-1Ra and CRP levels were monocyte activation during hemodialysis caused by con-
taminated dialysate may enhance the incidence of carpalsignificantly higher during the cuprophan period com-
pared with the Polyflux period [18]. These data suggest tunnel syndrome. Baz et al compared ESRD patients on
long-term (mean 6 years) cuprophan hemodialysis withthat moderately contaminated dialysate in combination
with the use of pyrogen-permeable dialyzer membranes ultrapure dialysate to those on cuprophan dialysis with
moderately contaminated standard dialysate. With stan-causes not only cytokine induction, but also elevated CRP
plasma levels. It has to be emphasized, however, that dard dialysate, 24 out of 103 patients developed carpal
tunnel syndrome, whereas only 2 out of 84 patients treatedunder the conditions of hemodialysis with Polyflux as
well as in our study using low-flux polysulfone, CRP levels with ultrapure dialysate showed carpal tunnel syndrome
(P , 0.05) [25]. A more recent retrospective analysis byremained significantly higher than in healthy controls.
According to these new data, optimized hemodialysis Schwalbe et al also suggests that improved water and
dialysate quality as well as the more frequent use oftherapy using ultrapure dialysate and biocompatible (py-
rogen-adsorbing) dialyzer membranes is able to reduce, synthetic dialyzer membranes may be associated with a
decreased prevalence of b2-microglobulin amyloidosisbut not to normalize, elevated CRP levels in ESRD pa-
[26]. Although monocyte activation and cytokines weretients. Therefore, hemodialysis-independent inducers of
not assessed in the studies by Baz et al and Schwalbe etmicroinflammation have to be identified. Possible dialysis-
al, the results are in agreement with the concept thatindependent inducers of monocyte activation, cytokine
contaminated dialysate may cause monocyte activationinduction, and CRP elevation include chronic infections,
with the consequence of enhanced tissue inflammationfor example, with Chlamydia pneumoniae, cytomegalovi-
and progressive b2-microglobulin amyloidosis.rus, or Helicobacter pylori, advanced glycation end (AGE)
Cardiovascular diseases are one of the most predomi-products, advanced oxidation protein products (AOPP),
nant causes of death in patients with end-stage renaloxidized low-density lipoprotein, and others [19–22].
failure. In chronic renal patients, risk factors of cardio-Taken together, hemodialysis-dependent and hemodial-
vascular diseases include hypertension, hypervolemia,ysis-independent inducers of monocyte activation should
smoking, high cholesterol, anemia, and a state of micro-be identified and treated or prevented in order to reduce
inflammation. The relevance of inflammation in the patho-the contribution of an inflammatory response to chronic
genesis of atherosclerosis is supported by several in vitrodiseases associated with long-term hemodialysis therapy.
studies as well as clinical investigations. Pretreatment of
human arterial intimal smooth muscle cells enhances the
MICROINFLAMMATION AND CHRONIC expression of adhesion molecules and subsequent adher-
DISEASES IN ESRD PATIENTS ence of monocytes/macrophages [27]. Human monocyte–
A state of microinflammation contributes to malnutri- endothelial interaction induces platelet-derived growth
tion by several routes, including reduction of appetite factor (PDGF) expression in endothelial cells, and this
and less food intake, a decrease in albumin synthesis, PDGF expression depends on monocyte-derived IL-1b
and catabolic degradation of muscle proteins leading to and TNF-a production [28]. Long-term exposure of vas-
loss of lean body mass [16, 17, 23]. Recently, a series of cular endothelium to IL-1b and TNF-a causes endothe-
studies by Miyata, Inagi, and Kurokawa provided evi- lial dysfunction called “stunning” [29] and intimal thick-
dence that there is a role of microinflammation also in the ening as well as coronary vasospasm in pigs, which is
pathogenesis of b2-microglobulin amyloidosis [reviewed in mediated by IL-1b–induced PDGF [30]. Taken together,
24]. A part of b2-microglobulin is modified to AGE-b2- these studies support the concept that monocyte activa-
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